Showing results (81-90 of 137) with videos related to
Sort By:
Pageof 14
The British Journal of Dermatology|December 1, 1990
Necrolytic migratory erythema: association with neuroendocrine tumour with predominant insulin secretionS M Wilkinson, P H Cartwright, C Allen, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1980
The use of choline chloride in ataxic disordersC M Lawrence, P Millac, G S Stout, et al.Biochemical Pharmacology|June 1, 1983
Aryl hydrocarbon hydroxylase activity and psoriasisM J Finnen, S Shuster, C M Lawrence, et al.Human Resources for Health|December 10, 2019
'Everything was just getting worse and worse': deteriorating job quality as a driver of doctor emigration from IrelandN Humphries, A M McDermott, E Conway, et al.Physiological Measurement|July 2, 1999
Duodenogastric reflux of bile in health: the normal rangeJ P Byrne, R Romagnoli, P Bechi, et al.Biochemistry|September 17, 1996
Structural determinants of nucleotide coenzyme specificity in the distinctive dinucleotide binding fold of HMG-CoA reductase from Pseudomonas mevaloniiJ A Friesen, C M Lawrence, C V Stauffacher, et al.Journal of Molecular Biology|April 29, 1994
Crystallization and preliminary X-ray analysis of the low molecular weight phosphotyrosyl protein phosphatase from bovine heartM Zhang, R L Van Etten, C M Lawrence, et al.Archives of Dermatology|January 1, 1990
Dermatomyositis. Disease associations and an evaluation of screening investigations for malignancyN H Cox, C M Lawrence, J A Langtry, et al.The British Journal of Dermatology|March 29, 2000
Basal cell carcinoma: are early appointments justifiable?P M Gordon, N H Cox, W D Paterson, et al.Acta Crystallographica. Section D, Biological Crystallography|May 1, 1995
Crystallization of HMG-CoA reductase from Pseudomonas mevaloniiC M Lawrence, Y I Chi, V W Rodwell, et al.Pageof 14